Literature DB >> 32209760

Decoding epigenetic codes: new frontiers in exploring recovery from spinal cord injury.

Bo-Yin Zhang1, Peng-Yu Chang2, Qing-San Zhu1, Yu-Hang Zhu1.   

Abstract

Spinal cord injury that results in severe neurological disability is often incurable. The poor clinical outcome of spinal cord injury is mainly caused by the failure to reconstruct the injured neural circuits. Several intrinsic and extrinsic determinants contribute to this inability to reconnect. Epigenetic regulation acts as the driving force for multiple pathological and physiological processes in the central nervous system by modulating the expression of certain critical genes. Recent studies have demonstrated that post-SCI alteration of epigenetic landmarks is strongly associated with axon regeneration, glial activation and neurogenesis. These findings not only establish a theoretical foundation for further exploration of spinal cord injury, but also provide new avenues for the clinical treatment of spinal cord injury. This review focuses on the epigenetic regulation in axon regeneration and secondary spinal cord injury. Together, these discoveries are a selection of epigenetic-based prognosis biomarkers and attractive therapeutic targets in the treatment of spinal cord injury.

Entities:  

Keywords:  axon regeneration; epigenetic biomarkers; epigenetic modification; histone; microRNA; prognosis; secondary injury; spinal cord injury

Year:  2020        PMID: 32209760     DOI: 10.4103/1673-5374.276323

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  5 in total

1.  Unlocking the Recovery Potential: JMJD3 Inhibition-Mediated SAPK/JNK Signaling Inactivation Supports Endogenous Oligodendrocyte-Lineage Commitment Post Mammalian Spinal Cord Injury.

Authors:  Zhang Bo-Yin; Zhu Qingsan; Ma Yihang; Yang Fan; Zhu Yuhang; Chang Pengyu
Journal:  Neurochem Res       Date:  2021-01-11       Impact factor: 3.996

Review 2.  Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment.

Authors:  Paul Köhli; Ellen Otto; Denise Jahn; Marie-Jacqueline Reisener; Jessika Appelt; Adibeh Rahmani; Nima Taheri; Johannes Keller; Matthias Pumberger; Serafeim Tsitsilonis
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

3.  Selection of suitable internal controls for gene expression normalization in rats with spinal cord injury.

Authors:  Wei Liu; Jie Yu; Yi-Fan Wang; Qian-Qian Shan; Ya-Xian Wang
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

4.  A Bibliometric Analysis of Publications on Spinal Cord Injury Treatment With Glucocorticoids Using VOSviewer.

Authors:  Yu Zhang; An-An Li; Shi-Ning Xiao; Nan-Shan Zhong; Wei-Lai Tong; Shi-Jiang Wang; Jia-Ming Liu; Zhi-Li Liu
Journal:  Front Public Health       Date:  2022-08-08

Review 5.  Endocrinological and inflammatory markers in individuals with spinal cord injury: A systematic review and meta-analysis.

Authors:  Gabriela Boehl; Peter Francis Raguindin; Ezra Valido; Alessandro Bertolo; Oche Adam Itodo; Beatrice Minder; Patricia Lampart; Anke Scheel-Sailer; Alexander Leichtle; Marija Glisic; Jivko Stoyanov
Journal:  Rev Endocr Metab Disord       Date:  2022-08-18       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.